| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Jun 15, 2026 | Sale | $60.71 | 5,538 | 336,212 | 15,437 | Jun 17, 2026, 07:12 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 19, 2026 | Sale | $65.51 | 199 | 13,036 | 20,975 | May 21, 2026, 06:26 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 18, 2026 | Sale | $73.00 | 180 | 13,140 | 21,174 | Feb 20, 2026, 07:10 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Jan 20, 2026 | Sale | $35.67 | 3,867 | 137,936 | 21,354 | Jan 22, 2026, 07:31 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 25, 2025 | Sale | $54.28 | 1,157 | 62,802 | 18,971 | Nov 25, 2025, 08:30 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Sep 04, 2025 | Sale | $33.52 | 1,721 | 57,693 | 18,390 | Sep 08, 2025, 08:32 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Sep 02, 2025 | Sale | $30.10 | 485 | 14,599 | 19,183 | Sep 04, 2025, 09:02 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 19, 2025 | Sale | $26.59 | 725 | 19,278 | 19,668 | Aug 21, 2025, 09:05 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 19, 2025 | Sale | $0.67 | 10,712 | 7,177 | 305,892 | May 21, 2025, 08:08 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 19, 2025 | Sale | $1.01 | 10,300 | 10,403 | 316,604 | Feb 21, 2025, 06:07 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Dec 19, 2024 | Sale | $0.94 | 51,115 | 48,048 | 326,904 | Dec 20, 2024, 08:33 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 19, 2024 | Sale | $1.01 | 7,785 | 7,863 | 243,019 | Nov 20, 2024, 08:37 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 19, 2024 | Sale | $1.28 | 6,866 | 8,788 | 250,804 | Aug 20, 2024, 09:15 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 17, 2024 | Sale | $1.75 | 7,355 | 12,871 | 257,670 | May 20, 2024, 09:13 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 20, 2024 | Sale | $0.68 | 9,014 | 6,130 | 265,025 | Feb 22, 2024, 08:19 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 17, 2023 | Sale | $0.49 | 9,646 | 4,727 | 274,039 | Nov 20, 2023, 09:02 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 16, 2023 | Sale | $0.78 | 9,703 | 7,568 | 283,685 | Aug 17, 2023, 08:08 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 16, 2023 | Sale | $0.72 | 9,791 | 7,050 | 293,388 | May 17, 2023, 08:29 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 16, 2023 | Sale | $3.00 | 10,484 | 31,452 | 303,179 | Feb 17, 2023, 09:00 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 16, 2022 | Sale | $3.57 | 13,460 | 48,052 | 313,663 | Nov 18, 2022, 06:05 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 18, 2022 | Sale | $4.65 | 73,716 | 342,779 | 327,123 | Aug 19, 2022, 06:27 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 16, 2022 | Sale | $4.76 | 10,560 | 50,266 | 400,839 | Aug 17, 2022, 07:41 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 16, 2022 | Sale | $3.95 | 21,673 | 85,608 | 276,399 | May 17, 2022, 09:40 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 16, 2022 | Sale | $10.95 | 10,912 | 119,486 | 274,122 | Feb 18, 2022, 06:20 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 16, 2021 | Sale | $13.16 | 20,869 | 274,636 | 232,084 | Nov 17, 2021, 06:11 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 16, 2021 | Sale | $13.83 | 7,662 | 105,965 | 212,803 | Aug 18, 2021, 07:04 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 16, 2021 | Sale | $22.37 | 24,141 | 540,034 | 266,176 | Feb 18, 2021, 07:07 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 23, 2020 | Sale | $16.40 | 16,380 | 268,632 | 250,317 | Nov 25, 2020, 06:09 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 16, 2020 | Sale | $16.93 | 29,618 | 501,433 | 266,697 | Nov 18, 2020, 07:08 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Aug 17, 2020 | Sale | $19.67 | 26,200 | 515,354 | 296,315 | Aug 19, 2020, 06:41 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | May 18, 2020 | Sale | $22.51 | 4,558 | 102,601 | 322,515 | May 20, 2020, 06:33 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Feb 18, 2020 | Sale | $22.35 | 4,774 | 106,699 | 327,073 | Feb 20, 2020, 06:39 PM | |
| NKTR | NEKTAR THERAPEUTICS | Jonathan Zalevsky | Chief R&D Officer | Nov 18, 2019 | Sale | $17.97 | 3,960 | 71,161 | 291,697 | Nov 20, 2019, 07:07 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More